Periscope Capital Inc. Makes New $3.49 Million Investment in Oaktree Acquisition Corp. III Life Sciences $OACC

Periscope Capital Inc. acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 323,408 shares of the company’s stock, valued at approximately $3,488,000. Periscope Capital Inc. owned approximately 1.72% of Oaktree Acquisition Corp. III Life Sciences as of its most recent SEC filing.

Separately, Rangeley Capital LLC raised its position in shares of Oaktree Acquisition Corp. III Life Sciences by 52.8% during the first quarter. Rangeley Capital LLC now owns 61,188 shares of the company’s stock worth $647,000 after purchasing an additional 21,156 shares during the period.

Oaktree Acquisition Corp. III Life Sciences Stock Up 0.1%

OACC stock opened at $10.71 on Monday. Oaktree Acquisition Corp. III Life Sciences has a one year low of $10.50 and a one year high of $10.93. The firm has a 50-day moving average of $10.74 and a two-hundred day moving average of $10.70.

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC – Get Free Report) last announced its earnings results on Friday, November 13th. The company reported ($0.02) EPS for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised Oaktree Acquisition Corp. III Life Sciences from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 2nd. One research analyst has rated the stock with a Hold rating. According to MarketBeat.com, the stock currently has an average rating of “Hold”.

Read Our Latest Stock Analysis on Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences Profile

(Free Report)

Oaktree Acquisition Corp. III Life Sciences is a special purpose acquisition company (SPAC) formed to pursue a business combination with a company in the life sciences sector. Its potential transactions could include a merger, acquisition, or similar combination. The company was sponsored by Oaktree Capital Management. As a SPAC, it did not have its own operating business or sell products and services; its intended role was to identify and combine with a business in its target sector.

See Also

Institutional Ownership by Quarter for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

Receive News & Ratings for Oaktree Acquisition Corp. III Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Acquisition Corp. III Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.